Literature DB >> 15031256

Increase in non-evidence based use of antidepressants in children is cause for concern.

Antonio Clavenna, Maurizio Bonati, Elisa Rossi, Marisa De Rosa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15031256      PMCID： PMC381270          DOI： 10.1136/bmj.328.7441.711-c

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  3 in total

1.  FDA advisory panel calls for suicide warnings over new antidepressants.

Authors:  Ray Moynihan
Journal:  BMJ       Date:  2004-02-07

2.  Treatment of major depressive disorder in children and adolescents.

Authors:  Paul Ramchandani
Journal:  BMJ       Date:  2004-01-03

3.  Rising prevalence of antidepressants among US youths.

Authors:  Julie Magno Zito; Daniel J Safer; Susan DosReis; James F Gardner; Karen Soeken; Myde Boles; Frances Lynch
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124
  3 in total
  6 in total

1.  Use of psychotropic medications in Italian children and adolescents.

Authors:  Antonio Clavenna; Elisa Rossi; Marisa Derosa; Maurizio Bonati
Journal:  Eur J Pediatr       Date:  2006-10-07       Impact factor: 3.183

2.  Drug related problems and off-label drug treatment in children as seen at a drug information centre.

Authors:  Elin Kimland; Ulf Bergman; Synnöve Lindemalm; Ylva Böttiger
Journal:  Eur J Pediatr       Date:  2006-12-29       Impact factor: 3.183

Review 3.  Predicting the clinical relevance of drug interactions from pre-approval studies.

Authors:  Silvio Caccia; Silvio Garattini; Luca Pasina; Alessandro Nobili
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

4.  Increase in psychotropic drug use between 2006 and 2010 among adolescents in Norway: a nationwide prescription database study.

Authors:  Anne Kjersti Myhrene Steffenak; Bodil Wilde-Larsson; Gun Nordström; Svetlana Skurtveit; Ingeborg Hartz
Journal:  Clin Epidemiol       Date:  2012-08-20       Impact factor: 4.790

Review 5.  Randomized controlled trials of serotonin-norepinephrine reuptake inhibitor in treating major depressive disorder in children and adolescents: a meta-analysis of efficacy and acceptability.

Authors:  Y Xu; S J Bai; X H Lan; B Qin; T Huang; P Xie
Journal:  Braz J Med Biol Res       Date:  2016-05-24       Impact factor: 2.590

6.  A three-country comparison of psychotropic medication prevalence in youth.

Authors:  Julie M Zito; Daniel J Safer; Lolkje T W de Jong-van den Berg; Katrin Janhsen; Joerg M Fegert; James F Gardner; Gerd Glaeske; Satish C Valluri
Journal:  Child Adolesc Psychiatry Ment Health       Date:  2008-09-25       Impact factor: 3.033
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.